Francesca Bernardini
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The bactericidal FabI inhibitor Debio 1453 clears antibiotic-resistant Neisseria gonorrhoeae infection in vivo.
Journal: Nature communications
Published: December 19, 2023
Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates.
Journal: The Journal of antimicrobial chemotherapy
Published: April 13, 2021
Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates.
Journal: The Journal of antimicrobial chemotherapy
Published: October 02, 2020
Author Correction: Chimeric peptidomimetic antibiotics against Gram-negative bacteria.
Journal: Nature
Published: November 24, 2019
Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator Antibiotics.
Journal: Antimicrobial agents and chemotherapy
Published: July 30, 2019
Pharmacokinetics and Pharmacodynamics of Murepavadin in Neutropenic Mouse Models.
Journal: Antimicrobial agents and chemotherapy
Published: August 11, 2018
Chimeric peptidomimetic antibiotics against Gram-negative bacteria.
Journal: Nature
Published: August 08, 2018
Efficacy of the Novel Antibiotic POL7001 in Preclinical Models of Pseudomonas aeruginosa Pneumonia.
Journal: Antimicrobial agents and chemotherapy
Published: March 03, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026